Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Chronic Heart Failure

Free Subscription 05.01.2026 3 Am J Cardiol 1 Ann Thorac Surg 1 Basic Res Cardiol 1 Cardiovasc Res 1 Circ Cardiovasc Interv 4 Circ Heart Fail 1 Circ Res 1 Circulation 5 Clin Cardiol 3 Int J Cardiol 4 J Am Coll Cardiol 3 J Card Fail 2 J Cardiol 2 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 5 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. JING H, Yang S, Zhang H, Tian Y, et al
   The "Block the Main Way" Technique for Left Ventricular Lead Implantation in Cardiac Resynchronization Therapy: A Case Report.
   Am J Cardiol. 2026;259:123-126.
   PubMed         Abstract available
   
   
2. XIA H, Li J, Dong J
   Corrigendum to 'Clinical Characteristics and Prognosis of Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease' [The American Journal of Cardiology 257(2025) Pages 101-109].
   Am J Cardiol. 2025 Dec 22:S0002-9149(25)00719.
   PubMed        
   
   
3. ANASTASIOU V, Stavropoulou E, Peteinidou E, Nikolaidou A, et al
   Dynamic Changes in Right Ventricular-Pulmonary Arterial Coupling during Acute Heart Failure Hospitalization: Prognostic Implications.
   Am J Cardiol. 2025 Dec 28:S0002-9149(25)00750.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. NAYAK A, Cascino TM, DeFilippis EM, Hanff TC, et al
   The Society of Thoracic Surgeons Intermacs 2025 Annual Report: Focus on Outcomes in Older Adults.
   Ann Thorac Surg. 2026;121:15-38.
   PubMed         Abstract available
   
   

   
   Basic Res Cardiol

5. PEREYRA KV, Schwarz KG, Diaz-Jara E, Vicencio SC, et al
   Peripheral chemoreceptors sustain central chemoreflex potentiation and cardiorespiratory abnormalities in high-output heart failure.
   Basic Res Cardiol. 2025 Dec 25. doi: 10.1007/s00395-025-01154.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

6. ZEDER K, Brown CH, Santi A, Cvirn L, et al
   The prevalence of pulmonary hypertension associated with left heart disease - a systematic review and meta-analysis.
   Cardiovasc Res. 2025 Nov 11:cvaf226. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Interv

7. EL-SABAWI B, Manandhar P, Butler J, Genereux P, et al
   Prediction of Heart Failure Hospitalization or Death After TAVR.
   Circ Cardiovasc Interv. 2025 Dec 31:e015398.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

8. VAN TASSELL BW, Golino M, Canada JM, Markley R, et al
   Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by Anakinra.
   Circ Heart Fail. 2025 Dec 23:e013546. doi: 10.1161/CIRCHEARTFAILURE.125.013546.
   PubMed         Abstract available
   
   
9. MILLER WL
   Blood Volume Expansion: Can an Adaptation of Endurance Training, Altitude Acclimatization, and Pregnancy Inform Volume Homeostasis in Chronic Heart Failure and Why Does It Matter? A Viewpoint.
   Circ Heart Fail. 2025 Dec 24:e013429. doi: 10.1161/CIRCHEARTFAILURE.125.013429.
   PubMed        
   
   
10. CARBONE S, Billingsley HE, Ahmed SI, Golino M, et al
    Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity-Related Heart Failure With Preserved Ejection Fraction: The UFA-Preserved2 Randomized Controlled Crossover Study.
    Circ Heart Fail. 2025 Dec 24:e013511. doi: 10.1161/CIRCHEARTFAILURE.125.013511.
    PubMed        
    
    
11. BLOOMFIELD GS, Watanabe M, McCallum S, Aberg JA, et al
    Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).
    Circ Heart Fail. 2025 Dec 29:e013382. doi: 10.1161/CIRCHEARTFAILURE.125.013382.
    PubMed         Abstract available
    
    

    
    Circ Res

12. HAYES JB, Choudhary D, Ritter D, Neininger-Castro AC, et al
    Nonmuscle alpha-Actinin-4 Couples Sarcomere Function to Cardiac Remodeling.
    Circ Res. 2026;138:e326412.
    PubMed         Abstract available
    
    

    
    Circulation

13. MARGONATO D, Enriquez-Sarano M, Nishihara T, Phichaphop A, et al
    Quantitative Identification of High-Risk Tricuspid Regurgitation by Cardiac Magnetic Resonance.
    Circulation. 2025 Nov 12. doi: 10.1161/CIRCULATIONAHA.125.074862.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

14. XIAO X, Yang Y, Zhang B, Chi K, et al
    Joint Exposure to Multiple Air Pollutants, Genetic Susceptibility, and Risk of Heart Failure in Cancer Patients: A Prospective Study in UK Biobank.
    Clin Cardiol. 2025;48:e70235.
    PubMed         Abstract available
    
    
15. KOZLUCA V, Akbulut IM, Tan TS, Gulyigit H, et al
    Diuretic Response Prediction With MELD Score in Heart Failure.
    Clin Cardiol. 2025;48:e70245.
    PubMed         Abstract available
    
    
16. BIBI Z
    Critical Evaluation of "GLP-1 and Dual GLP-1/GIP Receptor Agonists in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis".
    Clin Cardiol. 2025;48:e70249.
    PubMed        
    
    
17. KATAOKA N, Imamura T
    Optimal Heart Rate Modulation Therapy Using Ivabradine in Individuals With Acute Heart Failure.
    Clin Cardiol. 2025;48:e70248.
    PubMed        
    
    
18. GHIORZI J, Sill JD, Qayyum R
    Medicaid Expansion and 30-Day Mortality After Heart Failure Hospitalization: A Nationwide Study.
    Clin Cardiol. 2025;48:e70240.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

19. BELFORT DSP, Furlan DAG, Cafezeiro CRF, Wanderley MRB Jr, et al
    Impaired myocardial work in heart failure with improved ejection fraction: A post hoc analysis from the CATHEDRAL-HF trial.
    Int J Cardiol. 2025;447:134120.
    PubMed         Abstract available
    
    
20. SUN Z, Zhang X, Zhao Y, Luo Y, et al
    Investigating the association between QRS duration change under GDMT and cardiac structure/function alteration in heart failure: Insights from a study of 520 patients.
    Int J Cardiol. 2025 Dec 30:134134. doi: 10.1016/j.ijcard.2025.134134.
    PubMed         Abstract available
    
    
21. MORIMOTO J, Taruya A, Satogami K, Taniguchi M, et al
    Diastolic function at anaerobic threshold predicts 1-year outcomes in elderly patients with heart failure.
    Int J Cardiol. 2025 Dec 30:134136. doi: 10.1016/j.ijcard.2025.134136.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

22. HEIDENREICH P
    Health Quality and Policy: What This Means as a "Report Card" on Heart Failure Care.
    J Am Coll Cardiol. 2025;86:2574-2576.
    PubMed        
    
    
23. TATAVARTHY M, Spertus J
    Evolving Health Status Trends in Patients With Heart Failure: A Cause for Celebration or Concern?
    J Am Coll Cardiol. 2025;86:2571-2573.
    PubMed        
    
    
24. MCDONAGH TA, Piper SE, Plymen CM
    Increasing Heart Failure Prevalence: Clinical Implications and Challenges.
    J Am Coll Cardiol. 2025;86:2569-2570.
    PubMed        
    
    
25. KRUMHOLZ HM
    Heart Failure and Hypertension in the Metabolic Era: 2 Atlases, 1 Message.
    J Am Coll Cardiol. 2025;86:2539-2541.
    PubMed        
    
    

    
    J Card Fail

26. KRISHNAN V, Khan SS, Mefford MT, Shah NS, et al
    Proportional Mortality from Heart Failure and Cardiovascular-Kidney-Metabolic Comorbidities among Asian American, Native Hawaiian, and Other Pacific Islander Adults.
    J Card Fail. 2025 Dec 31:S1071-9164(25)01086.
    PubMed         Abstract available
    
    
27. BONNESEN K, Dahabreh IJ, Heide-Jorgensen U, Lash TL, et al
    Empagliflozin vs. dapagliflozin in heart failure: a target trial emulation.
    J Card Fail. 2025 Dec 29:S1071-9164(25)01079.
    PubMed         Abstract available
    
    
28. MENTIAS A, Keshvani N, Desai MY, Fonarow GC, et al
    Temporal Trends in Incidence and Prevalence of Heart Failure Hospitalization Among Medicare Beneficiaries.
    J Card Fail. 2025 Dec 29:S1071-9164(25)01085.
    PubMed         Abstract available
    
    

    
    J Cardiol

29. FUJIKI S, Minamisawa M, Nagata Y, Takahashi S, et al
    Baseline characteristics of patients with heart failure and mild cognitive impairment in Cog-HF trial.
    J Cardiol. 2025 Dec 24:S0914-5087(25)00314-4. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    
30. ABUELAZM M, Rakab MS, Altamimi I, Amin AM, et al
    Natriuresis-guided decongestion in acute decompensated heart failure: A systematic review and Meta-analysis.
    J Cardiol. 2025 Dec 28:S0914-5087(25)00312-0. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

31. LI M, Wang Y, Widdop RE
    Novel angiotensin receptor target as therapy for the diabetic heart: the AT(2)R.
    J Mol Cell Cardiol. 2026;210:83-97.
    PubMed         Abstract available
    
    
32. SHUMLIAKIVSKA M, Fischer A, Muhly-Reinholz M, Leonard VE, et al
    The long non-coding RNA Snhg15 protects the heart after myocardial infarction.
    J Mol Cell Cardiol. 2025 Oct 27:S0022-2828(25)00195.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

33. VINCY TAM WS, Calderon R, Lu S, Todd A, et al
    Active and passive cardiac indexes as complementary predictors of outcomes after left ventricular assist device implantation.
    J Thorac Cardiovasc Surg. 2026;171:218-228.
    PubMed         Abstract available
    
    

    
    N Engl J Med

34. BAVENDIEK U, Grosshennig A, Bauersachs J
    Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction. Reply.
    N Engl J Med. 2026;394:98.
    PubMed        
    
    
35. SHAMSULDDIN AB
    Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2026;394:97.
    PubMed        
    
    
36. CURTAIN JP
    Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2026;394:97.
    PubMed        
    
    
37. BOULIN M, Cransac-Miet A, Tannenbaum C
    Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2026;394:96-97.
    PubMed        
    
    
38. HOTHI SS, Lau C, Tan LB
    Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.
    N Engl J Med. 2026;394:96.
    PubMed        
    
    

    
    PLoS One

39. KESSINGER CW, Chen L, Huang F, Lin J, et al
    Diet-induced steatohepatitis does not cause heart failure with preserved ejection fraction in male middle-aged C57BL/6N mice.
    PLoS One. 2025;20:e0339642.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.